ESC 365 - 4 year outcomes in a prospective evaluation of transcatheter mitral valve-in-valve, valve-in-ring and valve-in-mitral annular calcification: results from the MITRAL trial.

ESC Professional Premium Access

4 year outcomes in a prospective evaluation of transcatheter mitral valve-in-valve, valve-in-ring and valve-in-mitral annular calcification: results from the MITRAL trial.

Session: Transcatheter valvular heart disease interventions: current paradigm and future directions

Topic: Mitral Valve Intervention

Speaker: Doctor M. Guerrero (Rochester, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Mayra Guerrero

Mayo Clinic, Rochester (United States of America)

3 presentations

0 follower

3 more presentations in this session

State-of-the-art lecture in: Transcatheter valvular heart disease interventions: current paradigm and future directions.

Speaker: Professor R. Kornowski (Petah Tikva, IL)

Three-year outcomes following transcatheter tricuspid valve edge-to-edge repair

Speaker: Professor J. Hausleiter (Munich, DE)

Predictors of clinical success after transcatheter para-valvular leak closure: an international prospective multicentre registry

Speaker: Mr S. Hascoet (Le Plessis Robinson, FR)

Access the full session

Transcatheter valvular heart disease interventions: current paradigm and future directions

Speakers: Doctor M. Guerrero, Professor R. Kornowski, Professor J. Hausleiter, Mr S. Hascoet

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources